Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  liposomal cytarabine-daunorubicin CPX-351
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
Liposomal Cytarabine-Daunorubicin CPX-351, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients with Relapsed or Refractory Acute Myeloid Leukemia
Status: Temporarily closed
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 1 to 21
Trial IDs: AAML1421, NCI-2015-01917, PAAML1421_R02PAPP01, NCT02642965
Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic Impairment
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 80
Trial IDs: CLTR0314-208, NCI-2015-02230, NCT02269579
CPX-351 in Treating Patients with Newly Diagnosed, High-Risk Acute Myeloid Leukemia
Status: Active
Phase: Phase II
Type: Treatment
Age: Over 18
Trial IDs: 2014-0548, NCI-2014-02529, NCT02286726
EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML
Status: Active
Phase: No phase specified
Type: Treatment
Age: 60 to 75
Trial IDs: CLTR0314-401, NCI-2016-00853, NCT02533115
Start Over